Details for New Drug Application (NDA): 202240
✉ Email this page to a colleague
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Pharmacology for NDA: 202240
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 202240
Suppliers and Packaging for NDA: 202240
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CELECOXIB | celecoxib | CAPSULE;ORAL | 202240 | ANDA | NCS HealthCare of KY, Inc dba Vangard Labs | 0615-8338 | 0615-8338-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8338-39) |
CELECOXIB | celecoxib | CAPSULE;ORAL | 202240 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8528 | 0615-8528-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8528-39) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Oct 29, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Jun 9, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Jun 9, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription